Equasens Société anonyme (ENXTPA: EQS)
Health Care · Health Care Technology · FR
€28.95
+0.87% today · -28.7% 1Y
Equasens Société anonyme (ENXTPA: EQS) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $483.00M and employs 1,462 people.
Over the last twelve months the share price has lost 28.7%, trading between 28.60 and 45.35.
Tweenvest scores Equasens Société anonyme across four factors: quality 86/100, value 89/100, growth 49/100, dividend 89/100. Its strongest factor is value.
EQS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $483.00M
- Revenue (TTM)
- $279.96M
- P/E
- 10.53
- EPS
- 2.72
- Dividend yield
- 4.93%
- Beta (5Y)
- 0.58
- 52-week high
- €45.35
- 52-week low
- €28.60
- Avg volume (3M)
- —
- Shares outstanding
- 15.03M
- Employees
- 1,462
- Next earnings
- —
About Equasens Société anonyme
Equasens S.A., established in 1996 and headquartered in Villers-les-Nancy, France, delivers a diverse portfolio of information technology solutions tailored for the European healthcare industry. The company primarily equips pharmacies and their networks with advanced management systems, including LGPI global services and OffiCentral. Pharmacists leverage a comprehensive suite of tools designed to streamline daily business operations, such as OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker. To foster stronger customer relationships and engagement, Equasens provides innovative solutions like OffiTag, OffiTouch, OffiMédia, OffiConnect, alongside automation systems and loyalty program management. Beyond operational software, the company offers analytical insights through its My Pilot tool and professional development opportunities via OffiLearning, an e-learning platform. A key area of focus is patient support, with offerings spanning compliance monitoring software, Multimeds, Automeds, OffiTéléconsult, and essential pharmaceutical and shared medical record services. The company's specialized systems include ULTIMATE, which combines efficient pharmacy administration with enhanced patient care, and FARMACLICK, a protocol facilitating communication between pharmacies and wholesale distributors (the latter also served by DIFARM). Additional retail management tools comprise PHARE and the SOPHIA pharmacy application, complemented by OffiMédia POS displays. Equasens also addresses specific health needs, such as chronic renal failure management with eNephro, and simplifies the administration of patient education programs through TPE Pilot. Further extending its reach across the healthcare sector, Equasens offers various dedicated solutions like NOVIACARE, CARELIB (for home and nursing home care), KAPELSE, TITAN, ANTHADINE software, the MOBISOINS mobile tool, MICROSOINS for in-home nursing care, and LOGICLIC. For holistic patient journey oversight, the AXIGATE solutions and CHORUS platform are available. Supplementary services include medical telesecretarial assistance for healthcare professionals and equipment lease financing options. Equasens S.A. functions as a subsidiary of Marque Verte Sante.
- ISIN
- FR0012882389
- Founded
- 1996
- Listed since
- Oct 25, 2000
- Exchange
- Euronext Paris
- Currency
- EUR
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Medlive Technology Co., Ltd.SEHK: 2192 | $621.51M | HK$6.59 | +2.49% |
| Heren Health Co.,Ltd.SZSE: 300550 | $546.83M | CN¥13.95 | +0.79% |
| Longmaster Information & Technology Co., Ltd.SZSE: 300288 | $493.43M | CN¥9.78 | +1.45% |
| Craneware plcAIM: CRW | $493.12M | £10.86 | -1.27% |
| GPI S.p.A.BIT: GPI | $481.96M | €15.14 | +1.61% |
| Medley, Inc.TSE: 4480 | $463.79M | ¥2,430.00 | +5.33% |
| Evolent Health, Inc.NYSE: EVH | $456.76M | $4.12 | +1.86% |
| Claritev CorporationNYSE: CTEV | $417.92M | $24.19 | -1.91% |
Figures last refreshed Oct 11, 2026.